Reduction in Opioid Prescribing Using a Postoperative Pain Management Protocol following Scrotal and Subinguinal Surgery

Starks, Christopher; Zampini, Anna; Tadros, Nicholas N.; McGill, John; Baker, Karen; Sabanegh, Edmund

doi:10.1016/j.urpr.2017.03.010

Cited by 8 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In patients who underwent penile, scrotal or subinguinal surgery Starks et al found a median use of 3 opioid pills. 9 In our study the number of pills prescribed at vasectomy in the opioid cohort ranged from 5 to 20. Two patients who presented to the emergency room for scrotal pain received prescriptions for 40 opioid tablets.…”

Section: Discussionmentioning

confidence: 92%

Routine Prescription of Opioids for Post-Vasectomy Pain Control Associated with Persistent Use

et al. 2019

View full text Add to dashboard Cite

Purpose: The AUA (American Urological Association) Position Statement on opioid use recommends using opioids only when necessary. We sought to determine if routine prescribing of opioids is necessary for pain control after vasectomy, and if an association exists with persistent use. Materials and Methods: We retrospectively reviewed the charts of patients who underwent vasectomy in clinic between April 2017 and March 2018. Patients were stratified into 2 groups, including those initially prescribed opioids and those not receiving opioid prescriptions at the time of vasectomy. The initial pain medication regimen depended on the standard prescription practice of each provider. Encounters with a medical provider for scrotal pain within 30 days, subsequent opioid prescriptions and new persistent opioid prescriptions between 90 and 180 days were compared between the 2 groups using the Fisher exact test. Results: Between April 2017 and March 2018 a total of 228 patients underwent clinic vasectomy as performed by 8 urologists. At the time of vasectomy 102 patients received opioid prescriptions and 126 received no opioid prescriptions. There was no statistically significant difference between the opioid and nonopioid groups in encounters for scrotal pain (12.7% vs 18.4%, p [ 0.279). The incidence of new persistent opioid use was 7.8% in the opioid cohort compared to 1.5% in the nonopioid cohort (p [ 0.046). Conclusions: Opioids, which do not appear to be necessary in men who undergo vasectomy, were associated with persistent use in 7.8% of patients at 3 to 6 months. In the face of an opioid epidemic urologists should take action to limit over prescription of opioids after vasectomy.

show abstract

Section: Discussionmentioning

confidence: 92%